Immunotherapy: Combined immunotherapy--a new standard in metastatic melanoma?

Affiliations

¹ University Hospital of Schleswig-Holstein, Campus Kiel, Department of Dermatology, Schittenhelmstrasse 7, 24105 Kiel, Germany.
² Division of Dermatooncology, Department of Dermatology, University Medical Center, Liebermeisterstrasse 25, 72074 Tuebingen, Germany.

Comment

Axel Hauschild et al. Nat Rev Clin Oncol. 2015 Aug.

. 2015 Aug;12(8):439-40.

doi: 10.1038/nrclinonc.2015.118. Epub 2015 Jun 23.

¹ University Hospital of Schleswig-Holstein, Campus Kiel, Department of Dermatology, Schittenhelmstrasse 7, 24105 Kiel, Germany.
² Division of Dermatooncology, Department of Dermatology, University Medical Center, Liebermeisterstrasse 25, 72074 Tuebingen, Germany.

No abstract available

Comment on

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.
Postow MA, Chesney J, Pavlick AC, Robert C, Grossmann K, McDermott D, Linette GP, Meyer N, Giguere JK, Agarwala SS, Shaheen M, Ernstoff MS, Minor D, Salama AK, Taylor M, Ott PA, Rollin LM, Horak C, Gagnier P, Wolchok JD, Hodi FS. Postow MA, et al. N Engl J Med. 2015 May 21;372(21):2006-17. doi: 10.1056/NEJMoa1414428. Epub 2015 Apr 20. N Engl J Med. 2015. PMID: 25891304 Free PMC article. Clinical Trial.